Since 2020, private equity has dominated U.S. healthcare M&A with over 3,600 deals, far outpacing health systems’ 450 deals. But this imbalance may be shifting. By pairing private equity-style strategy with long-term stability, traditional health systems can win in a competitive M&A market.